Understand that maintaining weight loss likely means maintaining 40-60% of loss, not all of it The Structured Transition Protocol If youre attempting this path, heres the evidence-based approach that gives you the best chance: Month 1-2: Gradual Taper Week 1-2: Reduce dose by 25% Week 3-4: Reduce to 50% of original dose Week 5-6: Reduce to 25% of original dose Week 7-8: Discontinue completely Rationale: Sudden cessation causes abrupt return of hunger signals
[1] Differential diagnoses [2] Intra-abdominal abscess Pancreatic pseudocyst Cystic neoplasm Pseudosacculation (e.g., in Crohn disease) Management [1] [2] No treatment is required for asymptomatic individuals
Researchers envision pairing GLP-1s with psychotherapy or digital craving-tracking apps to personalize dose titration
HGH (Somatropin): FDA-approved for specific indications: pediatric growth hormone deficiency, adult GHD, Turner syndrome, HIV/AIDS-related wasting, short bowel syndrome Prescription-only medication requiring physician monitoring Illegal to distribute for off-label purposes including anti-aging (per the 1990 Anabolic Steroids Control Act amendments) Brand names include Genotropin, Norditropin, Humatrope, Saizen CJC-1295 and Ipamorelin: Neither is FDA-approved for any therapeutic indication Available as research compounds for laboratory use only (RUO Research Use Only) Not scheduled substances, but not approved for human therapeutic use Ipamorelin has undergone Phase I/II clinical trials (Johansen et al., 1999) but development did not progress to approval For a deeper look at Ipamorelin's regulatory history, see our Ipamorelin FDA approval status guide